Correlation Between Orchestra BioMed and Mineralys Therapeutics,
Can any of the company-specific risk be diversified away by investing in both Orchestra BioMed and Mineralys Therapeutics, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Orchestra BioMed and Mineralys Therapeutics, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Orchestra BioMed Holdings and Mineralys Therapeutics, Common, you can compare the effects of market volatilities on Orchestra BioMed and Mineralys Therapeutics, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Orchestra BioMed with a short position of Mineralys Therapeutics,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Orchestra BioMed and Mineralys Therapeutics,.
Diversification Opportunities for Orchestra BioMed and Mineralys Therapeutics,
0.09 | Correlation Coefficient |
Significant diversification
The 3 months correlation between Orchestra and Mineralys is 0.09. Overlapping area represents the amount of risk that can be diversified away by holding Orchestra BioMed Holdings and Mineralys Therapeutics, Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Mineralys Therapeutics, and Orchestra BioMed is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Orchestra BioMed Holdings are associated (or correlated) with Mineralys Therapeutics,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Mineralys Therapeutics, has no effect on the direction of Orchestra BioMed i.e., Orchestra BioMed and Mineralys Therapeutics, go up and down completely randomly.
Pair Corralation between Orchestra BioMed and Mineralys Therapeutics,
Given the investment horizon of 90 days Orchestra BioMed Holdings is expected to generate 1.17 times more return on investment than Mineralys Therapeutics,. However, Orchestra BioMed is 1.17 times more volatile than Mineralys Therapeutics, Common. It trades about 0.08 of its potential returns per unit of risk. Mineralys Therapeutics, Common is currently generating about 0.05 per unit of risk. If you would invest 502.00 in Orchestra BioMed Holdings on August 28, 2024 and sell it today you would earn a total of 66.00 from holding Orchestra BioMed Holdings or generate 13.15% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Orchestra BioMed Holdings vs. Mineralys Therapeutics, Common
Performance |
| Timeline |
| Orchestra BioMed Holdings |
| Mineralys Therapeutics, |
Orchestra BioMed and Mineralys Therapeutics, Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Orchestra BioMed and Mineralys Therapeutics,
The main advantage of trading using opposite Orchestra BioMed and Mineralys Therapeutics, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Orchestra BioMed position performs unexpectedly, Mineralys Therapeutics, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mineralys Therapeutics, will offset losses from the drop in Mineralys Therapeutics,'s long position.| Orchestra BioMed vs. BCE Inc | Orchestra BioMed vs. CECO Environmental Corp | Orchestra BioMed vs. Ironveld Plc | Orchestra BioMed vs. Freedom Internet Group |
| Mineralys Therapeutics, vs. Eliem Therapeutics | Mineralys Therapeutics, vs. Scpharmaceuticals | Mineralys Therapeutics, vs. Milestone Pharmaceuticals | Mineralys Therapeutics, vs. Seres Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.
Other Complementary Tools
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. |